Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Decision regret in men living with and beyond non-metastatic prostate cancer in the UK: a population-based patient-reported outcome study.

Wilding S, Downing A, Selby P, Cross W, Wright P, Watson EK, Wagland R, Kind P, Donnelly DW, Hounsome L, Mottram R, Allen M, Kearney T, Butcher H, Gavin A, Glaser A.

Psychooncology. 2020 Feb 17. doi: 10.1002/pon.5362. [Epub ahead of print]

PMID:
32065691
2.

The ENABLE study protocol: Understanding and characterising the value and role of self-management support for people living with cancer that is treatable but not curable.

Calman L, Radcliffe E, Berman R, Demain S, Restorick-Banks S, Richardson A, Wagland R, Foster C.

Eur J Cancer Care (Engl). 2020 Jan 20:e13217. doi: 10.1111/ecc.13217. [Epub ahead of print]

PMID:
31958343
3.

Adjustment strategies amongst black African and black Caribbean men following treatment for prostate cancer: Findings from the Life After Prostate Cancer Diagnosis (LAPCD) study.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Collaco N, Alexis O, Gavin A, Glaser AW, Watson E.

Eur J Cancer Care (Engl). 2020 Jan;29(1):e13183. doi: 10.1111/ecc.13183. Epub 2019 Oct 23.

PMID:
31642565
4.

Quality of life among symptomatic compared to PSA-detected prostate cancer survivors - results from a UK wide patient-reported outcomes study.

Donnelly DW, Vis LC, Kearney T, Sharp L, Bennett D, Wilding S, Downing A, Wright P, Watson E, Wagland R, Cross WR, Mason MD, Siesling S, van Manen JG, Glaser AW, Gavin A.

BMC Cancer. 2019 Oct 15;19(1):947. doi: 10.1186/s12885-019-6164-5.

5.

The psychological impact of being on a monitoring pathway for localised prostate cancer: A UK-wide mixed methods study.

Matheson L, Wilding S, Wagland R, Nayoan J, Rivas C, Downing A, Wright P, Brett J, Kearney T, Cross W, Glaser A, Gavin A, Watson E.

Psychooncology. 2019 Jul;28(7):1567-1575. doi: 10.1002/pon.5133. Epub 2019 Jun 10.

PMID:
31132801
6.

Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapy.

Wilding S, Downing A, Wright P, Selby P, Watson E, Wagland R, Donnelly DW, Hounsome L, Butcher H, Mason M, Henry A, Gavin A, Glaser AW.

Qual Life Res. 2019 Oct;28(10):2741-2751. doi: 10.1007/s11136-019-02212-x. Epub 2019 May 21.

7.

Key factors associated with social distress after prostate cancer: Results from the United Kingdom Life after Prostate Cancer diagnosis study.

Wright P, Wilding S, Watson E, Downing A, Selby P, Hounsome L, Wagland R, Brewster DH, Huws D, Butcher H, Mottram R, Kearney T, Allen M, Gavin A, Glaser A.

Cancer Epidemiol. 2019 Jun;60:201-207. doi: 10.1016/j.canep.2019.04.006. Epub 2019 May 6.

8.

Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom.

Donnelly DW, Gavin A, Downing A, Hounsome L, Kearney T, McNair E, Allan D, Huws DW, Wright P, Selby PJ, Kind P, Watson E, Wagland R, Wilding S, Butcher H, Mottram R, Allen M, McSorley O, Sharp L, Mason MD, Cross WR, Catto JWF, Glaser AW.

Eur Urol. 2019 Aug;76(2):228-237. doi: 10.1016/j.eururo.2019.04.018. Epub 2019 May 4.

9.

Quality of life in men living with advanced and localised prostate cancer in the UK: a population-based study.

Downing A, Wright P, Hounsome L, Selby P, Wilding S, Watson E, Wagland R, Kind P, Donnelly DW, Butcher H, Catto JWF, Cross W, Mason M, Sharp L, Weller D, Velikova G, McCaughan E, Mottram R, Allen M, Kearney T, McSorley O, Huws DW, Brewster DH, McNair E, Gavin A, Glaser AW.

Lancet Oncol. 2019 Mar;20(3):436-447. doi: 10.1016/S1470-2045(18)30780-0. Epub 2019 Jan 31.

10.

'Very difficult for an ordinary guy': Factors influencing the quality of treatment decision-making amongst men diagnosed with localised and locally advanced prostate cancer: Findings from a UK-wide mixed methods study.

Wagland R, Nayoan J, Matheson L, Rivas C, Brett J, Downing A, Wilding S, Butcher H, Gavin A, Glaser AW, Watson E.

Patient Educ Couns. 2019 Apr;102(4):797-803. doi: 10.1016/j.pec.2018.12.004. Epub 2018 Dec 3.

11.

The challenges on the family unit faced by younger couples affected by prostate cancer: A qualitative study.

Collaço N, Wagland R, Alexis O, Gavin A, Glaser A, Watson EK.

Psychooncology. 2019 Feb;28(2):329-335. doi: 10.1002/pon.4944. Epub 2018 Dec 3.

PMID:
30444949
12.

Factors influencing job loss and early retirement in working men with prostate cancer-findings from the population-based Life After Prostate Cancer Diagnosis (LAPCD) study.

Bennett D, Kearney T, Donnelly DW, Downing A, Wright P, Wilding S, Wagland R, Watson E, Glaser A, Gavin A.

J Cancer Surviv. 2018 Oct;12(5):669-678. doi: 10.1007/s11764-018-0704-x. Epub 2018 Jul 30.

13.

A qualitative exploration of distress associated with episodic breathlessness in advanced lung cancer.

Stowe E, Wagland R.

Eur J Oncol Nurs. 2018 Jun;34:76-81. doi: 10.1016/j.ejon.2018.03.006. Epub 2018 Apr 10.

PMID:
29784142
14.

Prostate cancer and the impact on couples: a qualitative metasynthesis.

Collaço N, Rivas C, Matheson L, Nayoan J, Wagland R, Alexis O, Gavin A, Glaser A, Watson E.

Support Care Cancer. 2018 Jun;26(6):1703-1713. doi: 10.1007/s00520-018-4134-0. Epub 2018 Mar 6. Review.

PMID:
29511952
15.

Urinary, bowel and sexual health in older men from Northern Ireland.

Donnelly DW, Donnelly C, Kearney T, Weller D, Sharp L, Downing A, Wilding S, Wright P, Kind P, Catto JWF, Cross WR, Mason MD, McCaughan E, Wagland R, Watson E, Mottram R, Allen M, Butcher H, Hounsome L, Selby P, Huws D, Brewster DH, McNair E, Rivas C, Nayoan J, Horton M, Matheson L, Glaser AW, Gavin A.

BJU Int. 2018 Nov;122(5):845-857. doi: 10.1111/bju.14182. Epub 2018 Mar 25.

16.

Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England.

Wagland R, Bracher M, Drosdowsky A, Richardson A, Symons J, Mileshkin L, Schofield P.

BMJ Open. 2017 Sep 27;7(9):e017881. doi: 10.1136/bmjopen-2017-017881.

17.
18.

Facilitating early diagnosis of lung cancer amongst primary care patients: The views of GPs.

Wagland R, Brindle L, James E, Moore M, Esqueda AI, Corner J.

Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12704. Epub 2017 May 11.

19.

A qualitative metasynthesis exploring the impact of prostate cancer and its management on younger, unpartnered and gay men.

Matheson L, Watson EK, Nayoan J, Wagland R, Glaser A, Gavin A, Wright P, Rivas C.

Eur J Cancer Care (Engl). 2017 Nov;26(6). doi: 10.1111/ecc.12676. Epub 2017 Apr 5. Review.

PMID:
28382745
20.

Follow-up after curative treatment for colorectal cancer: longitudinal evaluation of patient initiated follow-up in the first 12 months.

Batehup L, Porter K, Gage H, Williams P, Simmonds P, Lowson E, Dodson L, Davies NJ, Wagland R, Winter JD, Richardson A, Turner A, Corner JL.

Support Care Cancer. 2017 Jul;25(7):2063-2073. doi: 10.1007/s00520-017-3595-x. Epub 2017 Feb 14.

21.

Life after prostate cancer diagnosis: protocol for a UK-wide patient-reported outcomes study.

Downing A, Wright P, Wagland R, Watson E, Kearney T, Mottram R, Allen M, Cairnduff V, McSorley O, Butcher H, Hounsome L, Donnelly C, Selby P, Kind P, Cross W, Catto JW, Huws D, Brewster DH, McNair E, Matheson L, Rivas C, Nayoan J, Horton M, Corner J, Verne J, Gavin A, Glaser AW.

BMJ Open. 2016 Dec 7;6(12):e013555. doi: 10.1136/bmjopen-2016-013555.

22.

Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study.

Wagland R, Brindle L, Ewings S, James E, Moore M, Rivas C, Esqueda AI, Corner J.

PLoS One. 2016 Nov 4;11(11):e0165677. doi: 10.1371/journal.pone.0165677. eCollection 2016.

23.

Prevalence of cancer chemotherapy-related problems, their relation to health-related quality of life and associated supportive care: a cross-sectional survey.

Wagland R, Richardson A, Ewings S, Armes J, Lennan E, Hankins M, Griffiths P.

Support Care Cancer. 2016 Dec;24(12):4901-4911. Epub 2016 Jul 27.

PMID:
27465050
24.
25.

Ethnicity and the prostate cancer experience: a qualitative metasynthesis.

Rivas C, Matheson L, Nayoan J, Glaser A, Gavin A, Wright P, Wagland R, Watson E.

Psychooncology. 2016 Oct;25(10):1147-1156. doi: 10.1002/pon.4222. Epub 2016 Aug 23. Review.

26.

Development and testing of a text-mining approach to analyse patients' comments on their experiences of colorectal cancer care.

Wagland R, Recio-Saucedo A, Simon M, Bracher M, Hunt K, Foster C, Downing A, Glaser A, Corner J.

BMJ Qual Saf. 2016 Aug;25(8):604-14. doi: 10.1136/bmjqs-2015-004063. Epub 2015 Oct 28.

27.

Health-related quality of life after colorectal cancer in England: a patient-reported outcomes study of individuals 12 to 36 months after diagnosis.

Downing A, Morris EJ, Richards M, Corner J, Wright P, Sebag-Montefiore D, Finan P, Kind P, Wood C, Lawton S, Feltbower R, Wagland R, Vernon S, Thomas J, Glaser AW.

J Clin Oncol. 2015 Feb 20;33(6):616-24. doi: 10.1200/JCO.2014.56.6539. Epub 2015 Jan 5.

PMID:
25559806
28.

Treatment-related problems experienced by cancer patients undergoing chemotherapy: a scoping review.

Wagland R, Richardson A, Armes J, Hankins M, Lennan E, Griffiths P.

Eur J Cancer Care (Engl). 2015 Sep;24(5):605-17. doi: 10.1111/ecc.12246. Epub 2014 Oct 8. Review.

PMID:
25296389
29.

Rebuilding self-confidence after cancer: a feasibility study of life-coaching.

Wagland R, Fenlon D, Tarrant R, Howard-Jones G, Richardson A.

Support Care Cancer. 2015 Mar;23(3):651-9. doi: 10.1007/s00520-014-2399-5. Epub 2014 Aug 27.

PMID:
25160492
30.

Uncertainty and anxiety in the cancer of unknown primary patient journey: a multiperspective qualitative study.

Richardson A, Wagland R, Foster R, Symons J, Davis C, Boyland L, Foster C, Addington-Hall J.

BMJ Support Palliat Care. 2015 Dec;5(4):366-72. doi: 10.1136/bmjspcare-2013-000482. Epub 2013 Nov 19.

PMID:
24644189
31.

Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings.

Armes J, Wagland R, Finnegan-John J, Richardson A, Corner J, Griffiths P.

Cancer Nurs. 2014 May-Jun;37(3):E52-60. doi: 10.1097/NCC.0b013e3182980420.

PMID:
24141376
32.

Patient-reported outcomes of cancer survivors in England 1-5 years after diagnosis: a cross-sectional survey.

Glaser AW, Fraser LK, Corner J, Feltbower R, Morris EJ, Hartwell G, Richards M, Wagland R.

BMJ Open. 2013 Apr 10;3(4). pii: e002317. doi: 10.1136/bmjopen-2012-002317. Print 2013.

33.

Qualitative analysis of patients' feedback from a PROMs survey of cancer patients in England.

Corner J, Wagland R, Glaser A, Richards SM.

BMJ Open. 2013 Apr 10;3(4). pii: e002316. doi: 10.1136/bmjopen-2012-002316. Print 2013.

34.

Coping with and factors impacting upon the experience of lung cancer in patients and primary carers.

Ellis J, Lloyd Williams M, Wagland R, Bailey C, Molassiotis A.

Eur J Cancer Care (Engl). 2013 Jan;22(1):97-106. doi: 10.1111/ecc.12003. Epub 2012 Sep 17.

PMID:
22978743
35.

The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool.

Molassiotis A, Ellis J, Wagland R, Williams ML, Bailey CD, Booton R, Blackhall F, Yorke J, Smith JA.

J Pain Symptom Manage. 2013 Feb;45(2):179-90. doi: 10.1016/j.jpainsymman.2012.01.015. Epub 2012 Aug 25.

36.

Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers.

Ellis J, Wagland R, Tishelman C, Williams ML, Bailey CD, Haines J, Caress A, Lorigan P, Smith JA, Booton R, Blackhall F, Molassiotis A.

J Pain Symptom Manage. 2012 Dec;44(6):831-42. doi: 10.1016/j.jpainsymman.2011.12.274. Epub 2012 Jun 5.

37.

Applying Best-Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer.

Molassiotis A, Emsley R, Ashcroft D, Caress A, Ellis J, Wagland R, Bailey CD, Haines J, Williams ML, Lorigan P, Smith J, Tishelman C, Blackhall F.

Lung Cancer. 2012 Jul;77(1):199-204. doi: 10.1016/j.lungcan.2012.02.001. Epub 2012 Mar 3.

PMID:
22385926
38.

Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals.

Wagland R, Ellis J, Bailey CD, Haines J, Caress A, Williams ML, Lorigan P, Smith J, Tishelman C, Booton R, Luker K, Blackhall F, Molassiotis A.

Support Care Cancer. 2012 Oct;20(10):2565-74. doi: 10.1007/s00520-011-1362-y. Epub 2012 Jan 20.

PMID:
22270088
39.

How standard is 'standard care' in the symptom management of patients with lung cancer? The example of the 'respiratory distress' symptom cluster.

Wagland R, Molassiotis A.

Eur J Oncol Nurs. 2011 Feb;15(1):1-2. doi: 10.1016/j.ejon.2010.12.001. Epub 2010 Dec 28. No abstract available.

PMID:
21193349
40.

An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses.

Bailey CD, Wagland R, Dabbour R, Caress A, Smith J, Molassiotis A.

BMC Pulm Med. 2010 Dec 9;10:63. doi: 10.1186/1471-2466-10-63. Review.

41.

The experience of cough in patients diagnosed with lung cancer.

Molassiotis A, Lowe M, Ellis J, Wagland R, Bailey C, Lloyd-Williams M, Tishelman C, Smith J.

Support Care Cancer. 2011 Dec;19(12):1997-2004. doi: 10.1007/s00520-010-1050-3. Epub 2010 Nov 24.

PMID:
21107612

Supplemental Content

Loading ...
Support Center